drugset / Trial / NCT07076498
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Phase 1
Recruiting
20 enrolled
M.D. Anderson Cancer Center
Congressionally Directed Medical Research Programs · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.
Timeline
- Start
- 2026-04-23
- Primary completion
- 2029-12-31
- Completion
- 2031-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | M032 | Unknown | — | Other |